David E. Huizenga, Co-founder, Ph.D. CEO

David is President and Chief Technology Officer of Tao Life Sciences. His expertise in commercialization routes and strategies comes from over 15 years of working with early stage technologies at numerous universities. He has worked closely with technology transfer offices in not only protecting their technology through patents, but also in helping them to decide how to deploy their limited resources. He is an expert in translating groundbreaking science into realistic commercial opportunities.

David has been involved in the analysis of numerous opportunities for company formation, both as a potential founder, as well as a consultant for the formation teams or IP owners, many of which have led to company formation. He brings over 15 years serving senior executives, scientists and professionals in Fortune 100 companies and leading academic institutions in all aspects of biotechnology patent value creation, counseling, and litigation.

While an Officer and Shareholder at Needle & Rosenberg PC, David was Vice President of Venture Investments where he worked closely on the integration of scientific, business and legal strategies to optimize commercial opportunities for his firm in non-traditional legal arrangements with clients, such as contingent fee arrangements and equity positions. David’s practice focused on small biotechnology and pharma opportunities and companies.

David has also served as Chief Technology Officer of Zirus Inc., a platform host target antiviral company where he was responsible for the integration of the company’s science, patent and business strategy.

David has a JD with Honors from Emory University School of Law and a Doctor of Philosophy in Genetics from Harvard University. He did his undergraduate studies in Biology and Chemistry at the University of San Diego, CA. He has numerous honors and recognitions including The Best Lawyers in America, 2007-2012 and Georgia Super Lawyers Rising Stars.


Randy Kirk, Co-founder and CTO

Founder and CEO Rad Source Technologies, Inc. 1997 to present. Randy established Rad Source Technologies Inc. to develop non-isotope irradiation replacements and commercialize them.  Those products have included the RS 2000 an x-ray research irradiator for use in medical research currently used by major universities and pharmaceutical companies around the world. The RS 3000, the world’s first X-ray irradiator for human transfusion blood received FDA 510 k marketing clearance in 1998 and was subsequently licensed to MDS Nordion.  

Currently the company markets a variety of irradiators designed to replace self-contained cesium units and cobalt units.  The current product line incorporates “4pi Emitter” technology.  “4pi Emitter” is the marketing designation for The Linear Target X-ray Source developed as a result of a phase 1 USDA SBIR in 1999.

Randy has been active in the Homeland Security movement to eliminate isotopes wherever possible and has testified for the National Academy of Sciences panel on Replacements for Class III Sources and the NRC panel concerning the same topic.  He has been an invited guest of the IAEA to present the possibility of x-ray replacing gamma sources for worldwide SIT applications and he provides input to various individuals and committees addressing these types of issues.


Dan Gorzen, Co-founder VP Engineering

After obtaining his B.S. in Physics from the University of Michigan in 1988, Dan worked as a Research Scientist at KMS Fusion Inc. Ann Arbor, MI. In 1991 he purchased KMS Fusion Inc., renaming it, X-ray and Specialty Instruments Inc., which he continues to run today.   Dan is also Vice President/Owner of Proto Manufacturing Inc, 2005 to presentFor the past 15 years, Dan has been involved in the research and development, production and marketing of x-ray sources and detection systems.  Dan is an experienced scientist and technologist with skills in x-ray detector calibrations, development of ultra-fast x-ray framing cameras, and design, fabrication, production and marketing of a broad spectrum of x-ray sources.  He has developed innovative and critical processes for the ultra high vacuum processing of these devices and in the development of their electronic controls.  Dan has received Phase I and Phase II SBIR grants, and is an inventor on a number of patents.


Mark J. Chandler, Co-founder, Advisor

Mark Chandler is the Chief Executive Officer of SC Technology Advancement Organization (SCTAO), where he leads the business, product development and financial operations.   Mark and has 25 years experience in the development, management and commercialization of advanced technology.

Mark was previously a Managing Director with Invotex Group, a US-based firm specializing in intellectual property (“IP”) and financial consulting services, where he led the firm’s activities in IP transactions, valuation and financing.  Prior to Invotex, Mark led corporate venturing activities for BTG plc, a UK-based technology investment and development firm.   In that capacity, he led his organization’s corporate venture group with over $50 million of capital and ten portfolio companies under management.

He has been involved in the creation or funding of more than ten companies in North America and Europe, all based around emerging technology and IP assets in areas such as medical technology, medical information, advanced electronics and photonics.  He has also served on the Board of Directors for several early-stage venture-backed companies.

He has previously worked for the AlliedSignal Corporation and Johns Hopkins University in the research, production and marketing of atomic clocks, precision measurement technologies and biomedical implantable devices. 

Mark received his Bachelor’s Degree in Electrical Engineering from Bucknell University and a Masters in Business Administration from the Wharton School of the University of Pennsylvania.  He has also earned the Certified Licensing Professional accreditation from the Licensing Professionals Society.


Brian S. Kirk, Co-founder, General Counsel

Brian Kirk brings a broad range of legal and business experience to the company with more than 13 years as a business lawyer in fortune 100 and start-up corporate law departments. His background includes a wide range of commercial transactions, as well as substantial experience in the areas of wireless, technology, complex transactions and disputes.

Since 2010, Brian has served as the Assistant General Counsel at ExteNet Systems, Inc., a mature start-up providing next-generation wireless networks to wireless carriers, where he is focused primarily on commercial transactions, new business ventures and regulatory matters. Prior to joining ExteNet, Brian served as a Senior Attorney at Motorola, Inc. in the company’s Mobile Devices Business and was responsible for legal counsel on all commercial aspects relating to Motorola’s largest U.S. carrier customers. Previously, Brian was an Attorney for the Global Supply Chain organization acting as the lead counsel for the company’s multiple global IT outsourcing relationships and handling IT and software transactions worldwide.

Brian is a founding member of the development company, Electonworks LLC, is a member of the board of directors for Rad Source, Inc. and has provided counsel on various legal and business matters for a number of start-up and small companies. He received his JD and Certificate in Intellectual Property Law with highest honors from Chicago-Kent College of Law, where he was a member of the Intellectual Property Law Journal and Order of the Coif.  He received his BS from Washington University in St. Louis.